Close
Novotech
Jabsco PureFlo 21 Single Use

Featured

Cold Chain Logistics: Powering Asia’s Biopharma Boom

As Asia’s healthcare systems mature, demand for the latest bio-pharmaceutical medicines is soaring. Most of these medicines are highly sensitive to temperature, meaning reliable cold chain services are crucial for effectively deploying biopharma across the region. And the need for...

The pharmaceutical supply chain: A digital future starts now

As TraceLink announces its Digital Network Platform aimed at transforming the global pharmaceutical supply chain to improve business performance and become more patient centric, we spoke to John Hogan, SVP, Engineering about digital supply chain strategies, the impact of...

How modern analytical instruments and intelligent software are accelerating metabolite identification in drug discovery and development

Intelligent technologies are transforming the pharmaceutical industry at a company and sector level, where tools such as artificial intelligence, machine learning and blockchain are pushing the limits of data analysis and accelerating decision-making. Meanwhile, similar technological progress is also...

The increase in global demand for in vitro performance testing models for topical products

The most common way to deliver a drug is systemically via an oral tablet or injection. In many cases, delivery of a drug via these routes may not be possible (poor bioavailability) or desirable (due to side effects); In...

Particle analysis: Growing demand with biologics

The development and introduction of new biological drug substances has been on the rise, and so have the regulatory requirements placed on these often life-saving products. At the same time, innovative analytical technologies have been developed that offer new...

The current scenario in Pharmaceutical Packaging Development

Ultra high barrier films protect any dosage content The Pharmaceutical Industry has always mainly focused on novel drug research, formulation development,  and  subsequent  clinical  trials.  As  with  all  other  phases  it  presents  its  own  challenges. There is no use if...

The Regenerative Medicine Supply Chain

Anticipate New Compliance Standards Now or Risk Falling Behind Overview While showing significant promise, regenerative medicine materials are inherently fragile and more at risk than other products during the supply chain process. Cross-contamination, orientation and handling problems, and equipment failure...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »